ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Big Names Line Up for Earnings Week

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Today brings results from AMAT — Applied Materials, one of the largest chip equipment makers on the market. Investors will scrutinise its Q3 numbers for signs of continued semiconductor spending. Also reporting today: NKTR (Nektar Therapeutics, $2.6B market cap), a biotech watch for pipeline updates.

Tomorrow, Friday Aug 14, sees further activity from smaller names across India and Asia.

The week's biggest cluster falls on Wednesday, Aug 19. LOW (Lowe's, $121B) and TGT (Target, $70B) both hold earnings calls — two retail bellwethers that will set the tone for consumer health. ADI (Analog Devices, $187B) reports Q3 results the same day. Chip investors will watch closely after a volatile stretch for the sector. EL (Estée Lauder, $22B) also reports. Its recovery story in China remains under scrutiny.

HD (Home Depot, $342B) drops Q2 results on Tuesday, Aug 18 — the week's standout report by market cap. Macro signals on housing will be the central focus.

Thursday, Aug 20 brings DE (Deere & Company, $167B). Farm equipment demand and global crop prices will drive the narrative. AAP (Advance Auto Parts, $3.2B) also holds its earnings call that morning.

Internationally, BHP reports full-year results on Tuesday. The mining giant's outlook on iron ore and copper will move markets across Asia and Europe. Swiss sanitaryware group GEBN (Geberit, $22B) also reports Wednesday.

No significant IPOs are currently scheduled for the coming seven days.

Stocks in this article

How this article was generated

Generated
13 Aug 2026, 16:31
Prompt version
v1.0
Data sources
Earnings

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.